Document is current
Any future updates will be listed below
-
Authors
Yuan, Qi
Dridi, Haikel
Clarke, Oliver B.
Reiken, Steven
Melville, Zephan
Wronska, Anetta
Kushnir, Alexander
Zalk, Ran
Sittenfeld, Leah
Marks, Andrew R.
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01HL145473)
National Institutes of Health (R01DK118240)
National Institutes of Health (R01HL142903)
National Institutes of Health (R01HL140934)
National Institutes of Health (R01AR070194)
National Institutes of Health (T32HL120826)
National Institutes of Health (R25 NS076445)
- License Information
-
More Information
Article History
Received: 26 October 2021
Accepted: 31 October 2021
First Online: 22 November 2021
Declarations
:
: ARM is on the scientific advisory board, board of directors and is an equity owner in ARMGO, Inc. a biotech company targeting RyR for therapeutic purposes, Columbia University also owns equity in ARMGO, Inc.
